In March 2025, the company introduced new ideas for any direct-to-client presenting of its Wegovy weight loss drug. The company recognized a completely new pharmacy, called NovoCare, which would charge buyers $499 every month for use of the drug, under fifty percent the price of the drug by means of other pharmaceutical distribution networks.[fifty